Universus Photo ImagingsNSE:UNIVPHOTO -0.21%52 Altman Z-Score is 17.46 as of Jul. 01, 2026, which is 23% above its 10-year median of 14.22. GuruFocus rates NSE:UNIVPHOTO with a GF Score™ of 52/100 and a GF Value™ of ₹177.21 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 808 Medical Devices & Instruments companies, Universus Photo Imagings ranks better than 92.08% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 17.84 is strong.
Universus Photo Imagings has a Altman Z-Score of 17.46, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Universus Photo Imagings's Altman Z-Score or its related term are showing as below:
NSE:UNIVPHOTO'
s Altman Z-Score Range Over the Past 10 Years
Min: 3.08 Med: 14.22 Max: 24.86
Current: 17.84
During the past 11 years, Universus Photo Imagings's highest Altman Z-Score was 24.86. The lowest was 3.08. And the median was 14.22.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:UNIVPHOTO vs ABT, SYK, MDT: Altman Z-Score Comparison
For the Medical Devices subindustry, Universus Photo Imagings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universus Photo Imagings Altman Z-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Universus Photo Imagings's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Universus Photo Imagings's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Universus Photo Imagings (NSE:UNIVPHOTO) has a Altman Z-Score of 17.46 as of Jul. 01, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Universus Photo Imagings and its competitors. This is 23% above median its historical median of 14.22. Over the past decade, Universus Photo Imagings' Altman Z-Score has ranged from 3.08 to 24.86. According to the industry distribution chart, Universus Photo Imagings ranks #64 out of 808 companies in the Medical Devices & Instruments industry, placing it in the top 7.9%.
Is Universus Photo Imagings' Altman Z-Score too high?
Universus Photo Imagings' current Altman Z-Score of 17.46 is 23% above median its 10-year median of 14.22. Over the past 10 years, this metric has ranged from a low of 3.08 to a high of 24.86. The Medical Devices & Instruments industry median Altman Z-Score is 2.89. Universus Photo Imagings' value of 17.46 is 505.2% above this industry median. Based on the distribution chart, Universus Photo Imagings ranks #64 out of 808 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Universus Photo Imagings has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universus Photo Imagings' Altman Z-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Universus Photo Imagings ranks #64 out of 808 companies for Altman Z-Score. This places Universus Photo Imagings in the top 8% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.89. Universus Photo Imagings' value of 17.46 is 505.2% above this benchmark. Historically, Universus Photo Imagings' own Altman Z-Score has ranged from 3.08 to 24.86 over the past decade. While the company's 10-year median is 14.22 vs. the industry median of 2.89, Universus Photo Imagings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 2.89, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universus Photo Imagings's current Altman Z-Score of 17.46 is 505.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Universus Photo Imagings and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universus Photo Imagings's current Altman Z-Score is 17.46, which is 23% above median its own 10-year median of 14.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universus Photo Imagings stock overvalued right now?
Based on GuruFocus' analysis, Universus Photo Imagings (NSE:UNIVPHOTO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹177.21, compared to a current price of ₹363.45 — trading 105.1% above its estimated fair value. The current Altman Z-Score is 17.46, which is 23% above median its 10-year median of 14.22 and 505.2% above the Medical Devices & Instruments industry median of 2.89. Universus Photo Imagings' overall GF Score™ is 52/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Universus Photo Imagings (NSE:UNIVPHOTO), the current Altman Z-Score is 17.46 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universus Photo Imagings (NSE:UNIVPHOTO) Overvalued in 2026?
Based on GuruFocus' analysis, Universus Photo Imagings stock appears to be overvalued.
The current stock price of ₹363.45 is trading 105.1% above its estimated GF Value™ of ₹177.21.
GuruFocus considers Universus Photo Imagings to be Significantly Overvalued.
Key valuation signals for NSE:UNIVPHOTO:
Altman Z-Score: 17.46 (23% above median its 10-year median of 14.22)
GF Value™: ₹177.21 vs. price of ₹363.45 (105.1% above fair value)
Industry Position: 505.2% above the Medical Devices & Instruments median (#64 of 808)
No single metric tells the full story. See the NSE:UNIVPHOTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universus Photo Imagings Ltd specializes in manufacturing, selling, distributing, converting, and producing X-ray films and NTR (non-toxic radiographic) films with matt and glossy finishes. These films are used for medical imaging and various photographic applications such as photo albums, certificates, playing cards, gift cards, visiting cards, calendars, menu cards, wedding cards, and modeling portfolios. The company operates a high-tech manufacturing facility located at Dadra in the Union Territory of Dadra and Nagar Haveli, India. Revenue is generated through the sale of these imaging products to medical and photographic industries.
52GF Score
Get the complete analysis for NSE:UNIVPHOTO
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:UNIVPHOTO has been successfully added to your 
